Table of Contents
Journal of Sexually Transmitted Diseases
Volume 2016, Article ID 5235269, 4 pages
http://dx.doi.org/10.1155/2016/5235269
Research Article

Immunological and Clinical Responses following the Use of Antiretroviral Therapy among Elderly HIV-Infected Individuals Attending Care and Treatment Clinic in Northwestern Tanzania: A Retrospective Cohort Study

1Department of Medicine, College of Health Sciences, The University of Dodoma, Dodoma, Tanzania
2Department of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania
3Department of Data Management, National Institute of Medical Research, Tukuyu Unit, Mbeya, Tanzania

Received 5 October 2015; Revised 9 February 2016; Accepted 14 February 2016

Academic Editor: Vincent C. Marconi

Copyright © 2016 Bonaventura C. T. Mpondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mahy, C. S. Autenrieth, K. Stanecki, and S. Wynd, “Increasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data,” AIDS, vol. 28, supplement 4, pp. S453–S459, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Negin and R. G. Cumming, “HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data,” Bulletin of the World Health Organization, vol. 88, no. 11, pp. 847–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Ball, “Increased longevity in HIV: caring for older HIV-infected adults,” Care Management Journals: Journal of Case Management; The Journal of Long Term Home Health Care, vol. 15, no. 2, pp. 76–82, 2014. View at Google Scholar
  4. A. Sankar, A. Nevedal, S. Neufeld, R. Berry, and M. Luborsky, “What do we know about older adults and HIV? a review of social and behavioral literature,” AIDS Care, vol. 23, no. 10, pp. 1187–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Arici, D. Ripamonti, V. Ravasio et al., “Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution,” International Journal of STD & AIDS, vol. 12, no. 9, pp. 573–581, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Grabar, I. Kousignian, A. Sobel et al., “Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV,” AIDS, vol. 18, no. 15, pp. 2029–2038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. G. R. Kaufmann, H. Furrer, B. Ledergerber et al., “Characteristics, determinants, and clinical relevance of CD4 T cell recovery to < 500 Cells/μL in HIV type 1—infected individuals receiving potent antiretroviral therapy,” Clinical Infectious Diseases, vol. 41, no. 3, pp. 361–372, 2005. View at Publisher · View at Google Scholar
  8. J.-P. Viard, A. Mocroft, A. Chiesi et al., “Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study,” The Journal of Infectious Diseases, vol. 183, no. 8, pp. 1290–1294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Cuzin, C. Delpierre, S. Gerard, P. Massip, and B. Marchou, “Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years,” Clinical Infectious Diseases, vol. 45, no. 5, pp. 654–657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Tumbarello, R. Rabagliati, K. De Gaetano Donati et al., “Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario,” AIDS, vol. 17, no. 1, pp. 128–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Tumbarello, R. Rabagliati, K. de Gaetano Donati et al., “Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy,” BMC Infectious Diseases, vol. 4, article 46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Blanco, I. Jarrín, M. Vallejo et al., “Definition of advanced age in HIV infection: looking for an age cut-off,” AIDS Research and Human Retroviruses, vol. 28, no. 9, pp. 1000–1006, 2012. View at Google Scholar · View at Scopus
  13. R. M. Grimes, M. E. Otiniano, M. C. Rodriguez-Barradas, and D. Lai, “Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy,” Clinical Infectious Diseases, vol. 34, no. 11, pp. 1530–1533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Knobel, A. Guelar, G. Valldecillo et al., “Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up,” AIDS, vol. 15, no. 12, pp. 1591–1593, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Orlando, P. Meraviglia, L. Cordier et al., “Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients,” HIV Medicine, vol. 7, no. 8, pp. 549–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Manfredi and F. Chiodo, “A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age,” AIDS, vol. 14, no. 10, pp. 1475–1477, 2000. View at Google Scholar
  17. R. C. Kalayjian, A. Landay, R. B. Pollard et al., “Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes,” The Journal of Infectious Diseases, vol. 187, no. 12, pp. 1924–1933, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Naylor, G. Li, A. N. Vallejo et al., “The influence of age on T cell generation and TCR diversity,” The Journal of Immunology, vol. 174, no. 11, pp. 7446–7452, 2005. View at Publisher · View at Google Scholar
  19. R. B. Effros, “T cell replicative senescence: pleiotropic effects on human aging,” Annals of the New York Academy of Sciences, vol. 1019, pp. 123–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Grabar, L. Weiss, and D. Costagliola, “HIV infection in older patients in the HAART era,” The Journal of Antimicrobial Chemotherapy, vol. 57, no. 1, pp. 4–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Mensforth, L. Goodall, N. Bodasing, and J. Coultas, “Late diagnosis among our ageing HIV population: a cohort study,” Journal of the International AIDS Society, vol. 17, supplement 3, no. 4, Article ID 19692, 2014. View at Publisher · View at Google Scholar
  22. R. D. Smith, V. C. Delpech, A. E. Brown, and B. D. Rice, “HIV transmission and high rates of late diagnoses among adults aged 50 years and over,” AIDS, vol. 24, no. 13, pp. 2109–2115, 2010. View at Publisher · View at Google Scholar